BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28193254)

  • 1. Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.
    Cohen N; Gupta M; Doerwald-Munoz L; Jang D; Young JE; Archibald S; Jackson B; Lee J; Chernesky M
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):11. PubMed ID: 28193254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.
    Guo M; Khanna A; Dhillon J; Patel SJ; Feng J; Williams MD; Bell DM; Gong Y; Katz RL; Sturgis EM; Staerkel GA
    Cancer Cytopathol; 2014 Feb; 122(2):96-103. PubMed ID: 24339259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
    Rohatensky MG; Livingstone DM; Mintchev P; Barnes HK; Nakoneshny SC; Demetrick DJ; Dort JC; van Marle G
    BMC Cancer; 2018 Feb; 18(1):166. PubMed ID: 29422018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
    Jo VY; Krane JF; Pantanowitz L; Monaco SE
    Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus detection in oropharyngeal cancer with gargle samples.
    Imai T; Sato I; Matsumoto K; Asada Y; Kato K; Sogai S; Watanabe K; Sadayasu R; Saijo S; Matsuura K
    B-ENT; 2016; 12(4):263-269. PubMed ID: 29709129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 11. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.
    Qureishi A; Mawby T; Fraser L; Shah KA; Møller H; Winter S
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2675-2683. PubMed ID: 28285422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours.
    Wasserman JK; Rourke R; Purgina B; Caulley L; Dimitroulakos J; Corsten M; Johnson-Obaseki S
    J Otolaryngol Head Neck Surg; 2017 Jan; 46(1):3. PubMed ID: 28061890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
    Lim MY; Dahlstrom KR; Sturgis EM; Li G
    Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
    Xu B; Ghossein R; Lane J; Lin O; Katabi N
    Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.